Products and Resources Catalog

This presentation discussed technology-assisted treatment for adolescent substance use. Presented by Alan Budney, PhD.

This presentation discussed trauma-informed approaches to the assessment and treatment of adolescent substance use. Presented by Kay Jankowski, Ph.D.

Conference Agenda

This presentation had three objectives1. Describe and discuss the potential impact of changes in cannabis laws and regulations 2. Describe the limitations of the evidence for cannabis as a therapeutic substance 3. Describe the primary concerns related to adolescents use of cannabis, and how the changing landscape interacts with these issues. Presented by Alan J. Budney, Ph.D.

The effects of prenatal alcohol exposure represent a leading preventable cause of developmental delays in the United States. Fetal alcohol spectrum disorders (FASD) represent the range of lifelong effects that can occur, including cognitive, behavioral, and/or social deficits. This lunch break will provide an overview of FASD and provide resources to adapt women’s treatment programs to increase success for women with an FASD.

In this webinar, Dr. Hill discusses the major myths about marijuana use and the challenges of treating marijuana addiction, including working with parents.

Q&A with marijuana expert Dr. Kevin Hill. Topics include Addiction/dependency, adolescence, effects on the body, medical marijuana, potency, and withdrawal.

This presentation discussed trauma-informed approaches to assessing and treating teens with substance use disorders. Presented by Carolyn Castro-Donlon A.L.M., M.A.

This presentation discussed challenges and opportunities working with adolescents with substance use disorders, with a focus on continuity of care. Presented by Yifrah Kaminer, M.D.

This presentation demonstrated how to use Motivational Interviewing with adolescents. Presented by Nadine Mastroleo, Ph.D. This presentation is proprietary.

Expert presenter bios at the 2015 Improving Care for Substance Use, HIV and/or HCV in Adolescents: Effective Approaches for Assessing, Treating, and Engaging Teens

This handout described how to monitor substance use in adolescents. Created by Catherine Stanger, Ph.D.

Adolescent Conference 2015 - Agenda

This presentation described: (1) the epidemics of HIV and HCV among US adolescents and young adults with regional examples. (2) the HIV continuum of care for Adolescents and Young Adults. (3) the value of HIV treatment, and current antiretroviral treatment guidelines and recent updates in care and treatment (4) how to incorporate HIV and HCV prevention, screening and linkage to care into your work with youth. Presented by Cathryn Samples, M.D.

Dr. Kari Franson from the University of Colorado's Skaggs School of Pharmacy and Pharmaceutical Sciences shares information on the long-term negative outcomes marijuana use has on developing adolescents.

Eight, 1-page color infographics (Four in English, four in Spanish) covering 1) Effects on the body 2) Use and educational outcomes, 3) Effects on pregnancy and newborns, and 4) Medical use.

Dr. Yifrah Kaminer from the University of Connecticut Health gives an overview of the latest research on the marijuana's effects on the brain and how legalization affects states' SUD treatment and prevention systems.

The purpose of this introductory training is to provide HIV clinicians (including, but not limited to physicians, dentists, nurses, and other allied medical staff, therapists and social workers, and counselors, specialists, and case managers) with a detailed overview of substance abuse and HIV among youth.

This revision of the March 2012 face-to-face version of the Pacific Southwest ATTC’s SBIRT curriculum was prepared by the National Screening, Brief Intervention and Referral to Treatment ATTC. The goals of the training remain the same: to help participants to develop skills related to SBIRT, and to begin a conversation around implementation of SBIRT in standard practice. The revised curriculum expands the format and presents the trainer with the opportunity to focus on any 1 of 4 option.

The purpose of this introductory training package is to provide clinicians from a variety of work and educational backgrounds with a detailed overview of synthetic drugs, including substances known on the street as K2, Spice, and Bath Salts. The presentation seeks to raise awareness by defining key terms, describing the main classes of synthetic drugs commonly available, presenting available data on the extent of use, providing information on how to identify and assess individuals using them.

These practice guidelines are framed by the notions of recovery and resilience. It is this framework, and an unwavering belief in recovery and resilience in behavioral health, that should be the basis for service delivery.

In recognition of Recovery Month 2011, this year's essay contest invited individuals who have been supported in their recovery by medications, including methadone or buprenorphine for opioid addiction and acamprosate or naltrexone for alcohol addiction, to share their stories.

The Journal of the Arizona Dental Association-Inscriptions, Volume 25, Number 13, September 2011 featured an article focused on the potential of patient abuse of prescription drugs, especially opioid based medication prescribed by dental practitioners to manage pain. Provided in the article are data and ways to engage patients in conversation regarding their prescription drug use.

This book comprises 20 essays in which family members described, in their own words, the most challenging part about having a family member with a substance use disorder, what it means to have a loved one find long-term recovery and explain why they are committed to recovery.